Pro-apoptotic BID in DNA Damage and Leukemogenesis
DNA 损伤和白血病发生中的促凋亡 BID
基本信息
- 批准号:7246734
- 负责人:
- 金额:$ 38.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The Bcl-2 family constitutes a crucial checkpoint in the cell death pathway. BID is a member of the "BH3- only" subset of this family and requires its conserved BH3 domain for its pro-apoptotic function. BID plays an important role in the apoptotic pathway downstream of death receptors such as TNF R1 and Fas. Cleavage by caspase 8 and myristoylation serve to activate BID, facilitating targeting to the mitochondria where it activates multidomain pro-apoptotic family members such as BAX or BAK, and activating the downstream apoptotMice in which Bid has been deleted undergo all normal developmental deaths. Aging Bid- deficient mice fail to maintain myeloid homeostasis, progressing to a fatal, clonal disorder that closely resembles human Chronic Myelomonocytic Leukemia (CMML). Thus, this single "BH3-only" protein thus plays a critical role in maintenance of normal myeloid homeostasis and tumor suppression. In addition to its role in apoptosis, we have uncovered a role for BID in regulating the DNA damage-induced intra-S phase checkpoint that does not require its death-promoting BH3 domain. Following DNA damage, BID is found in the nucleus, phosphorylated by ATM, and plays a role in the intra-S phase checkpoint. Thus, BID has two distinct and separable functions, an apoptotic function mediated by caspase cleavage and its BHS-domain, and a cell cycle/DMA repair function mediated by phosphorylation by the DNA damage kinase ATM. One of the central problems in the DNA damage and apoptotic pathways is how cells determine their response to DNA damage. Some cells arrest the cell cycle, and others undergo apoptosis. We hypothesize that BID acts at the interface between the DNA damage response and apoptosis, in position to execute the decision of a cell to undergo cell cycle arrest and initiate DNA repair or to undergo apoptosis. We propose to directly test this hypothesis by dissecting the mechanism of Bid function on both sides of this molecular switch. An understanding of the regulatory mechanisms that govern a cell's decision to activate cell cycle checkpoints or to undergo apoptosis has important implications for how cells respond to current cancer therapy, and should lead to important clues to new therapeutic targets.
描述(由申请人提供):BCL-2家族在细胞死亡途径中构成了关键检查点。出价是该家族“仅BH3-”子集的成员,并要求其保守的BH3域才能促凋亡。投标在死亡受体(例如TNF R1和FAS)下游的凋亡途径中起重要作用。 caspase 8和肉豆蔻酰化的裂解可激活投标,促进靶向线粒体,在那里它激活多域的促凋亡家族成员,例如bax或bak,并激活下游的poptotmice,其中销售了所有正常发育的竞标。衰老的竞标不足小鼠无法维持髓样稳态,发展为致命的,克隆疾病,与人类慢性脊髓细胞性白血病(CMML)非常相似。因此,这种单一的“仅BH3”蛋白在维持正常髓样稳态和抑制肿瘤方面起着关键作用。除了其在凋亡中的作用外,我们还发现了竞标在调节DNA损伤引起的S相检查点中的作用,该检查点不需要其促进死亡的BH3结构域。在DNA损伤后,在核中发现了出价,被ATM磷酸化,并在S Intra Intra相相检查点中起作用。因此,投标具有两个不同的可分离函数,这是由胱天蛋白酶裂解及其BHS域介导的凋亡功能,以及通过DNA损伤激酶ATM磷酸化介导的细胞周期/DMA修复功能。 DNA损伤和凋亡途径中的主要问题之一是细胞如何确定其对DNA损伤的反应。一些细胞阻止了细胞周期,而另一些细胞会经历凋亡。我们假设投标作用于DNA损伤反应和凋亡之间的界面,以便执行细胞对经过细胞周期停滞并启动DNA修复或进行凋亡的决定。我们建议通过剖析该分子开关两侧的投标机理直接检验该假设。对控制细胞激活细胞周期检查点或进行凋亡的决定的调节机制的理解对细胞如何应对当前的癌症治疗具有重要意义,并应为新的治疗靶标提供重要的线索。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Sandra S Zinkel其他文献
Acetaminophen Inhibits Cytochrome C Redox Cycling Induced Cardiolipin Oxidation in Mitochondria
- DOI:10.1016/j.freeradbiomed.2012.10.29810.1016/j.freeradbiomed.2012.10.298
- 发表时间:2012-11-012012-11-01
- 期刊:
- 影响因子:
- 作者:Aurélia Vergeade;Huiyong Yin;Qiong Shi;William E Zackert;Katherine C Gruenberg;Magdalena Bokiej;Taneem Amin;Weizhen Ying;Tina S Masterson;Sandra S Zinkel;John A Oates;Olivier Boutaud;L. Jackson Roberts IIAurélia Vergeade;Huiyong Yin;Qiong Shi;William E Zackert;Katherine C Gruenberg;Magdalena Bokiej;Taneem Amin;Weizhen Ying;Tina S Masterson;Sandra S Zinkel;John A Oates;Olivier Boutaud;L. Jackson Roberts II
- 通讯作者:L. Jackson Roberts IIL. Jackson Roberts II
共 1 条
- 1
Sandra S Zinkel的其他基金
Programmed necrosis regulation of leukemic transformation
白血病转化的程序性坏死调控
- 批准号:1001248610012486
- 财政年份:2020
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Programmed necrosis regulation of leukemic transformation
白血病转化的程序性坏死调控
- 批准号:1047721710477217
- 财政年份:2020
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Mechanisms of necrosis regulation of hematopoietic stem cell function
坏死调节造血干细胞功能的机制
- 批准号:99214929921492
- 财政年份:2018
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Necrosis regulation of bone marrow function
骨髓功能的坏死调节
- 批准号:86339098633909
- 财政年份:2014
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Pro-apoptotic BID in DNA Damage and Leukemogenesis
DNA 损伤和白血病发生中的促凋亡 BID
- 批准号:78373117837311
- 财政年份:2009
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Pro-apoptotic BID in DNA Damage and Leukemogenesis
DNA 损伤和白血病发生中的促凋亡 BID
- 批准号:74830357483035
- 财政年份:2007
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Pro-apoptotic BID in DNA Damage and Leukemogenesis
DNA 损伤和白血病发生中的促凋亡 BID
- 批准号:76903497690349
- 财政年份:2007
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Pro-apoptotic BID in DNA Damage and Leukemogenesis
DNA 损伤和白血病发生中的促凋亡 BID
- 批准号:79215127921512
- 财政年份:2007
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Bid Function in Myeloid Homeostasis and Leukemogenesis
Bid 在骨髓稳态和白血病发生中的功能
- 批准号:71219557121955
- 财政年份:2004
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Bid Function in Myeloid Homeostasis and Leukemogenesis
Bid 在骨髓稳态和白血病发生中的功能
- 批准号:69520256952025
- 财政年份:2004
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
相似国自然基金
基于巨噬细胞表型转变探讨BTSA1诱导衰老肌成纤维细胞凋亡及促肺纤维化消退的机制
- 批准号:82370077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
- 批准号:32360836
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
ATAD3A琥珀酰化调控mtDNA损伤-泛凋亡反应轴在心梗后心衰中的作用研究
- 批准号:82300434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胸腺肽α-1介导凋亡小体RNA改善DC功能增强TNBC化疗后抗肿瘤免疫应答的机制研究
- 批准号:82303959
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
LSD1通过使组蛋白H3K4位点去甲基化促进自噬参与肾小管上皮细胞凋亡和肾脏纤维化的机制研究
- 批准号:82300769
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Signaling Cell Death from the Endoplasmic Reticulum
内质网发出细胞死亡信号
- 批准号:82232818223281
- 财政年份:2009
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Pro-apoptotic BID in DNA Damage and Leukemogenesis
DNA 损伤和白血病发生中的促凋亡 BID
- 批准号:78373117837311
- 财政年份:2009
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Signaling Cell Death from the Endoplasmic Reticulum
内质网发出细胞死亡信号
- 批准号:76616707661670
- 财政年份:2009
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Signaling Cell Death from the Endoplasmic Reticulum
内质网发出细胞死亡信号
- 批准号:80383028038302
- 财政年份:2009
- 资助金额:$ 38.36万$ 38.36万
- 项目类别:
Signaling Cell Death from the Endoplasmic Reticulum
内质网发出细胞死亡信号
- 批准号:84482698448269
- 财政年份:2009
- 资助金额:$ 38.36万$ 38.36万
- 项目类别: